[1] DEY S,PATHAK D C,RAMAMURTHY N,et al.Infectious bursal disease virus in chickens:Prevalence,impact,and management strategies[J].Veterinary Medicine:Research and Reports,2019,10:85-97. [2] YILMAZ A,TURAN N,BAYRAKTAR E,et al.Phylogeny and evolution of Infectious bursal disease virus circulating in Turkish broiler flocks[J].Poultry Science,2019,98(5):1976-1984. [3] MYINT O,SUWANRUENGSRI M,ARAKI K,et al.Bursa atrophy at 28 days old caused by variant Infectious bursal disease virus has a negative economic impact on broiler farms in Japan[J].Avian Pathology:Journal of the WVPA,2021,50(1):6-17. [4] LEE C C,KO T P,CHOU C C,et al.Crystal structure of Infectious bursal disease virus VP2 subviral particle at 2.6A resolution:Implications in virion assembly and immunogenicity[J].Journal of Structural Biology,2006,155(1):74-86. [5] WU H,YANG H,JI G,et al.SUMO1 modification facilitates Avibirnavirus replication by stabilizing polymerase VP1[J].Journal of Virology,2019,93(10):e02227-18. [6] LUQUE D,RIVAS G,ALFONSO C,et al.Infectious bursal disease virus is an icosahedral polyploid dsRNA virus[J].Proceedings of the National Academy of Sciences of the United States of America,2009,106(7):2148-2152. [7] KIBENGE F S,QIAN B,CLEGHORN J R,et al.Infectious bursal disease virus polyprotein processing does not involve cellular proteases[J].Archives of Virology,1997,142(12):2401-2419. [8] RAUTENSCHLEIN S,ALKIE T N.Infectious bursal disease virus in poultry:Current status and future prospects[J].Veterinary Medicine Research and Reports,2016,7:9-18. [9] MATA C P,MERTENS J,FONTANA J,et al.The RNA-binding protein of a double-stranded RNA virus acts like a scaffold protein[J].Journal of Virology,2018,92(19):e00968-18. [10] WANG Z,MI J,WANG Y,et al.Recombinant Lactococcus expressing a novel variant of Infectious bursal disease virus VP2 protein can induce unique specific neutralizing antibodies in chickens and provide complete protection[J].Viruses,2020,12(12):1350. [11] FAHEY K J,ERNY K,CROOKS J.A conformational immunogen on VP-2 of Infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens[J].The Journal of General Virology,1989,70(Pt 6):1473-1481. [12] MULLER H,MUNDT E,ETERRADOSSI N,et al.Current status of vaccines against infectious bursal disease[J].Avian Pathology,2012,41(2):133-139. [13] 王彦伟,张素玲,吴 芃,等.鸡传染性法氏囊病病毒rVP2蛋白高效组装亚病毒颗粒的鉴定[J].中国畜牧兽医,2020,47(6):1677-1684. WANG Y W,ZHANG S L,WU P,et al.Identification of subviral particles efficiently self-assembled by Infectious bursal disease virus rVP2 protein[J].China Animal Husbandry & Veterinary Medicine,2020,47(6):1677-1684.(in Chinese) [14] MISHRA R P N,YADAV R S P,JONES C,et al.Structural and immunological characterization of E.coli derived recombinant CRM(197) protein used as carrier in conjugate vaccines[J].Bioscience Reports,2018,38(5):BSR20180238. [15] ROBERTSON C A,GREENBERG D P,HEDRICK J,et al.Safety and immunogenicity of a booster dose of meningococcal(groups A,C,W,and Y) polysaccharide diphtheria toxoid conjugate vaccine[J].Vaccine,2016,34(44):5273-5278. [16] PECETTA S,TONTINI M,FAENZI E,et al.Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination.Immunological comparison between CRM197 and diphtheria toxoid[J].Vaccine,2016,34(20):2334-2341. [17] COLLIER R J.Diphtheria toxin:Mode of action and structure[J].Bacteriological Reviews,1975,39(1):54-85. [18] WANG Z,DURAN-STRUUCK R,CREPEAU R,et al.Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin[J].Bioconjugate Chemistry,2011,22(10):2014-2020. [19] 闫 伟,杨 娜,毛若雨,等.噬菌体裂解酶Lysep3的毕赤酵母重组表达和活性分析[J].中国畜牧兽医,2020,47(4):1018-1027. YAN W,YANG N,MAO R Y,et al.Recombinant expression and activity analysis of phage lyase Lysep3[J].China Animal Husbandry & Veterinary Medicine,2020,47(4):1018-1027(in Chinese) [20] 尹训南,司昌德.IBDV地方毒株毒力测定的病理组织学检验标准探讨[J].中国预防兽医学报,1997,2:52-54. YIN X N,SI C D.Discussion on histopathological test criteria for virulence determination of local strains of IBDV[J].Chinese Journal of Preventive Veterinary Medicine,1997,2:52-54.(in Chinese) [21] MARUSIC C,DRISSI TOUZANI C,BORTOLAMI A,et al.The expression in plants of an engineered VP2 protein of Infectious bursal disease virus induces formation of structurally heterogeneous particles that protect from a very virulent viral strain[J].PLoS One,2021,16(2):e0247134. [22] TAGHAVIAN O,SPIEGEL H,HAUCK R,et al.Protective oral vaccination against Infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris[J].PLoS One,2013,8(12):e83210. [23] 段马魁.传染性法氏囊病病毒VP2蛋白的体外表达及免疫保护效果评价[D].太谷:山西农业大学,2018. DUAN M K.Expression of Infectious bursal disease virus VP2 protein in vitro and evaluation of its immunoprotective effect[D].Taigu:Shanxi Agricultural University,2018.(in Chinese) [24] DELIC M,VALLI M,GRAF A B,et al.The secretory pathway:Exploring yeast diversity[J].FEMS Microbiology Reviews,2013,37(6):872-914. [25] MATTANOVICH D,BRANDUARDI P,DATO L,et al.Recombinant protein production in yeasts[J].Methods in Molecular Biology,2012,824:329-358. [26] CASADEVALL A,PIROFSKI L A.A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens[J].Advances in Immunology,2006,91:1-44. [27] BADAHDAH A M,RASHID H,KHATAMI A.Update on the use of meningococcal serogroup C CRM197-conjugate vaccine (Meningitec) against meningitis[J].Expert Review of Vaccines,2016,15(1):9-29. [28] PARIJS B A,MALINOSKI F J.Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunization[J].Mechanisms of Ageing and Development,2004,125(2):147-148. [29] 于 雷,王秀丽,杨承槐,等.传染性法氏囊病病毒BC6/85株全基因组克隆及其序列分析[J].中国兽药杂志,2013,47(12):17-21. YU L,WANG X L,YANG C H,et al.Sequence analysis of the complete genome of IBDV BC6/85[J].Chinese Journal of Veterinary Drug,2013,47(12):17-21.(in Chinese) |